Pharmacological stress myocardial perfusion imaging with the potent and selective A2A adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection

Circulation

Volumn 104, Issue 10, 2001, Pages 1181-1187

  Glover, David K ^a   Ruiz, Mirta ^a   Takehana, Kazuya ^a   Petruzella, Frank D ^a   Riou, Laurent M ^a   Rieger, Jayson M ^a   Macdonald, Timothy L ^a   Watson, Denny D ^a   Linden, Joel ^a   Beller, George A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Adenosine; Imaging; Vasodilation

Indexed keywords

2 PROPYNYLCYCLOHEXYL 5' N ETHYLCARBOXAMIDOADENOSINE DERIVATIVE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; ATL 193; BINODENOSON; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ADOLESCENT; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DOSE RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; HEART SCINTISCANNING; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

EID: 0035806947     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3601.093983     Document Type: Article

References (22)

1. Tolerance and safety of pharmacologic coronary vasodilatation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease
2. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging
3. Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Trial Registry
4. Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study
5. 1 adenosine receptor-mediated effects in humans
6. 2-Alkoxyadenosines: Potent and selective agonists at the coronary artery A2 adenosine receptor
7. 2-N-alkylidenehyrdrazinoadenosines: Potent and selective coronary vasodilators
8. CGS-21680: A potent selective adenosine A2 receptor agonist
9. 2A receptor agonists
10. 2A receptor agonist
11. 2A receptor agonist
12. Turnover of adenosine in plasma of human and dog blood
13. 2A receptor agonists
14. 1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs
15. Characterization of human A(2B) adenosine receptors: Radioligand binding, Western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells
16. Calculating the dissociation constant of an unlabeled compound from the concentration required to displace radiolabel binding by 50%
17. Blood flow measurements with radionuclide-labeled particles
18. 2A receptor antagonist
19. 99 m Tc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity
20. 99mTc-sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: Implications for dobutamine stress testing
21. 2A adenosine receptor mediates coronary vasodilation
22. 125I]iodoplienyl)ethylamino]adenosine